Dashboard
Manage Tickers

CMND Clearmind Medicine Inc.

Nasdaq clearmindmedicine.com


$ 0.94 $ 0.00 (0.1 %)    

Thursday, 16-Oct-2025 13:55:03 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 592.55 $ 0.00 (0 %)
DIA $ 455.78 $ 0.00 (0 %)
SPY $ 653.87 $ 0.00 (0 %)
TLT $ 91.52 $ 0.00 (0 %)
GLD $ 399.90 $ 0.00 (0 %)
$ 0.9473
$ 0.96
$ 0.91 x 100
$ 0.96 x 11
-- - --
$ 0.80 - $ 2.18
27,714
na
nm
$ 0.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
09/22/2025 12:09:30

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
09/19/2025 21:06:05

clearmind-medicine-enters-10m-convertible-note-agreement-with-institutional-investors-begins-with-555k-issuance-at-500k-purchase-price
Clearmind Medicine Enters $10M Convertible...
09/19/2025 12:21:40

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

Core News & Articles
Clearmind Medicine Publishes International...
08/07/2025 11:39:10

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

clearmind-medicine-receives-irb-approval-from-hadassah-medical-center-jerusalem-for-ongoing-phase-12a-clinical-trial-evaluating-cmnd-100-proprietary-meai-based-oral-drug-candidate-for-treatment-of-aud
Clearmind Medicine Receives IRB Approval F...
08/05/2025 12:22:29

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

Core News & Articles
SciSparc And Clearmind File International ...
07/30/2025 12:13:34

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

clearmind-medicine-completes-site-initiation-at-tel-aviv-sourasky-medical-center-for-phase-iiia-clinical-trial-evaluating-cmnd-100-proprietary-oral-drug-candidate-for-aud
Clearmind Medicine Completes Site Initiati...
07/23/2025 12:56:53

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

clearmind-expands-phase-iiia-clinical-trial-for-cmnd-100-with-activation-of-additional-site-at-johns-hopkins-university-school-of-medicine-and-enrollment-of-first-participant-at-clinical-site
Clearmind Expands Phase I/IIa Clinical Tri...
07/15/2025 12:13:54

clearmind-medicine-granted-us-patent-12350242-for-binge-behavior-regulators
Clearmind Medicine Granted U.S. Patent #12...
07/08/2025 20:00:49

https://ppubs.uspto.gov/api/pdf/downloadPdf/12350242?requestToken=eyJzdWIiOiJlMmEyMTIwZi01YWZmLTQ5NGMtYjFkYi1lZTVmMmQ3MzM4NDgiL...

clearmind-medicine-receives-irb-approval-from-tasmc-in-tel-aviv-for-ongoing-phase-12a-clinical-trial-evaluating-cmnd-100-for-aud-treatment
Clearmind Medicine Receives IRB Approval F...
07/03/2025 12:48:37

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

clearmind-doses-first-patient-in-phase-iiia-trial-of-psychedelic-based-cmnd-100-for-alcohol-use-disorder
Clearmind Doses First Patient In Phase I/I...
06/30/2025 13:22:40

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

clearmind-medicine-adds-hadassah-university-medical-center-as-new-clinical-site-for-phase-iiia-trial-evaluating-cmnd-100
Clearmind Medicine Adds Hadassah-Universit...
06/27/2025 13:01:04

clearmind-medicine-enrolls-first-patient-in-phase-iiia-clinical-trial-for-cmnd-100-proprietary-meai-based-oral-drug-candidate-for-treatment-of-aud
Clearmind Medicine Enrolls First Patient I...
06/25/2025 11:51:01

CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the...

clearmind-medicine-engages-government-and-political-affairs-consulting-and-lobbying-firm-to-support-advancing-psychedelic-based-treatments
Clearmind Medicine Engages Government And ...
06/24/2025 12:18:42

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

clearmind-adds-tel-aviv-hospital-to-psychedelic-drug-trial-for-alcohol-use-disorder
Clearmind Adds Tel Aviv Hospital to Psyche...
06/23/2025 11:56:11

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

clearmind-medicine-engages-government-and-political-affairs-firm-to-advance-psychedelic-therapeutics-and-regulatory-advocacy
Clearmind Medicine Engages Government And ...
06/12/2025 13:27:19

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

clearmind-medicine-enrolls-first-patient-in-phase-iiia-clinical-trial-for-cmnd-100-proprietary-meai-based-oral-drug-candidate-aimed-at-treating-alcohol-use-disorder
Clearmind Medicine Enrolls First Patient I...
06/05/2025 11:35:00

CMND-100 has the potential to provide an innovative and advanced treatment option for hundreds of millions of people around the...

Core News & Articles
SciSparc Announced That Its Collaboration ...
05/12/2025 11:36:49

The patent application relates to a combination treatment using Clearmind's 5-methoxy-2-aminoindane ("MEAI") and Sc...

Core News & Articles
SciSparc, Clearmind Collaboration Leads To...
04/25/2025 12:03:37

TEL AVIV, Israel, April 25, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) (the "Company" or "SciSparc"),...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION